Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Multicenter Study
. 2010 Mar;65(3):318-21.
doi: 10.1093/gerona/glp158. Epub 2009 Oct 20.

Potentially inappropriate medication use in older adults with mild cognitive impairment

Andrea L Weston  1 , Andrea M Weinstein, Cynthia Barton, Kristine Yaffe
Affiliations
Multicenter Study

Potentially inappropriate medication use in older adults with mild cognitive impairment

Andrea L Weston et al. J Gerontol A Biol Sci Med Sci. 2010 Mar.

Abstract

Background: Patients with mild cognitive impairment (MCI) may be especially vulnerable to the side effects of potentially inappropriate medications (PIMs), especially those that impair cognition.

Methods: We conducted a cross-sectional study to determine the prevalence of PIM use among 689 patients with MCI. We used the 2003 Beers Criteria for cognitive impairment to identify PIMs. We then determined if certain patients were more likely to use PIMs.

Results: There were 143 (20.8%) patients with MCI taking a PIM: 108 (15.7%) patients were taking one PIM and 35 (5.1%) patients were taking two or more PIMs. The most common PIMs were anticholinergics (35.7%) and benzodiazepines (31.5%). Patients were more likely to be taking PIMs if they were women and were taking a greater number of medications and less likely if they had a history of myocardial infarction.

Conclusions: Patients with MCI are frequently taking PIMs that may negatively affect cognition. Future research is needed to assess whether cognitive impairment symptoms are improved if PIM use is reduced.

PubMed Disclaimer

References

    1. Fick DM, Cooper JW, Wade WE, et al. Updating the Beers Criteria for potentially inappropriate medication use in older adults. Arch Intern Med. 2003;163:2716–2724. - PubMed
    1. Barton CB, Sklenicka J, Sayegh P, et al. Contraindicated medication use among patients in a memory disorders clinic. Am J Geriatr Pharmacother. 2008;6:147–152. - PubMed
    1. Huey ED, Taylor JL, Luu P, et al. Factors associated with use of medications with potential to impair cognition or cholinesterase inhibitors among Alzheimer’s disease patients. Alzheimers Dement. 2006;2:314–321. - PMC - PubMed
    1. Ancelin ML, Artero S, Portet F, et al. Non-degenerative mild cognitive impairment in elderly people and use of anticholinergic drugs: longitudinal cohort study. BMJ. 2006;332:455–459. - PMC - PubMed
    1. Brooks JO, Hoblyn JC. Neurocognitive costs and benefits of psychotropic medications in older adults. J Geriatr Psychiatry Neurol. 2007;20:199–214. - PubMed

Publication types